Your search for bevacizumab returned 154 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for bevacizumab returned 154 results

Sort Results:

Relevant Recent
news

The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology’s 2011 Annual Meeting.

Bevacizumab-adcd 100mg, 400mg; per vial; soln for IV infusion after dilution; preservative-free.

Bevacizumab-bvzr 100mg, 400mg; per vial; soln for IV infusion after dilution; preservative-free.

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of October. The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com. Key: D=Dosing,…

Bevacizumab 100mg, 400mg; per vial; soln for IV infusion after dilution; preservative-free.